Clinical Trials Directory

Trials / Unknown

UnknownNCT02910245

Mercaptopurine Therapy in Ulcerative Colitis

Efficacy of Optimized Thiopurine Therapy in Ulcerative Colitis (OPTIC)

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
136 (estimated)
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This project is a double-blind, randomized, placebo-controlled, multicenter trial in the Netherlands. The aim of this study is to investigate the therapeutic efficacy of optimized 6-mercaptopurine (6-MP) in ulcerative colitis patients. Therapeutic drug monitoring (TDM) will be performed in order to optimize treatment outcomes and objective endoscopic endpoints will be used.

Detailed description

Subjects will receive treatment with oral prednisone 40 mg/day for 2 weeks, followed by fixed tapering over 6 weeks. Half of the subjects will be randomized to concomitant 6-MP 1-1.5 mg/kg/day and half will receive concomitant placebo treatment. During the entire course of the trial all subjects will receive maintenance treatment with 5-ASA in an oral dose of at least 2 gram per day. Subjects will be subjected to one colonoscopy at baseline and one sigmoidoscopy in week 52 in order to assess endoscopic disease activity. Data will be collected using electronic case report forms (eCRF) with Castor EDC. Quality and data validation procedures will be applied to ensure the validity and accuracy of the clinical database. Monitoring of the study will be done according to the GCP guidelines and following a monitoring plan. The financier of the study, ZonMw Goed Gebruik Geneesmiddelen, has the right to perform an audit if seen necessary.

Conditions

Interventions

TypeNameDescription
DRUGMercaptopurine (Purinethol)
DRUGPlacebo
DRUGMesalamine
DRUGPrednisone

Timeline

Start date
2016-11-01
Primary completion
2022-04-30
Completion
2022-04-30
First posted
2016-09-22
Last updated
2020-01-07

Locations

12 sites across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT02910245. Inclusion in this directory is not an endorsement.